US Stock MarketDetailed Quotes

Quantum BioPharma (QNTM)

Watchlist
  • 6.780
  • +1.310+23.95%
Trading May 14 15:34 ET
43.38MMarket Cap-0.88P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quantum BioPharma (QNTM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-14.06%2.91M
-3.57%15.32M
-61.23%2.36M
14.36%4.66M
41.57%4.91M
50.26%3.39M
-18.84%15.88M
202.91%6.09M
45.48%4.07M
-36.45%3.47M
Selling and administrative expenses
34.11%2.16M
28.98%12.01M
27.53%2.16M
25.26%4.02M
73.36%4.22M
-18.51%1.61M
-29.49%9.31M
-11.66%1.69M
19.42%3.21M
-11.22%2.44M
-General and administrative expense
34.11%2.16M
28.98%12.01M
27.53%2.16M
25.26%4.02M
73.36%4.22M
-18.51%1.61M
-29.49%9.31M
-11.66%1.69M
19.42%3.21M
-11.22%2.44M
Research and development costs
-62.02%626.09K
-54.58%2.76M
-98.36%70.4K
-33.51%495.22K
-38.84%549.2K
928.55%1.65M
57.63%6.08M
14,386.34%4.28M
2,358.00%744.8K
-44.24%897.99K
Depreciation amortization depletion
-1.74%127.44K
11.25%545.78K
14.69%129.37K
20.30%145.34K
3.34%141.38K
7.95%129.69K
-80.43%490.57K
-7.70%112.8K
-17.71%120.81K
-87.64%136.81K
-Depreciation and amortization
-1.74%127.44K
11.25%545.78K
14.69%129.37K
20.30%145.34K
3.34%141.38K
7.95%129.69K
-80.43%490.57K
-7.70%112.8K
-17.71%120.81K
-87.64%136.81K
Operating profit
14.06%-2.91M
3.57%-15.32M
61.23%-2.36M
-14.36%-4.66M
-41.57%-4.91M
-50.26%-3.39M
18.84%-15.88M
-202.91%-6.09M
-45.48%-4.07M
36.45%-3.47M
Net non-operating interest income expense
84.06%-45.18K
-172.82%-382.56K
-56.47%50.34K
-103.03%-4.66K
-250.77%-144.84K
-277.00%-283.4K
-33.17%525.31K
-24.80%115.64K
-12.01%153.5K
-48.40%96.07K
Non-operating interest income
----
-58.79%236.08K
-116.87%-22.29K
-38.72%100.42K
-13.11%90.73K
-61.04%67.22K
-27.15%572.89K
-14.12%132.08K
-5.86%163.87K
-43.91%104.42K
Non-operating interest expense
-87.11%45.18K
1,200.29%618.64K
-541.89%-72.62K
913.16%105.08K
2,718.87%235.57K
2,724.36%350.62K
15,812.04%47.58K
136,858.33%16.44K
--10.37K
--8.36K
Other net income (expense)
-112.96%-10.8M
-2,639.96%-11.26M
-370.65%-1.39M
11.45%-84.75K
-21,187.11%-4.71M
-302,296.54%-5.07M
-19.92%443.19K
152.25%514.89K
-106.41%-95.71K
110.41%22.33K
Gain on sale of security
-124.98%-8.49M
-3,909.49%-11.76M
-494.73%-1.35M
5.39%-102.2K
-29,364.89%-6.53M
-19,797.03%-3.77M
-272.22%-293.22K
-151.48%-226.67K
79.14%-108.03K
-96.80%22.33K
Special income (charges)
-119.34%-35.8K
-94.08%43.34K
-105.80%-42.78K
-8.69%11.25K
---110.27K
1,159.34%185.13K
116.08%732.42K
412.28%737.57K
--12.32K
--0
-Less:Impairment of capital assets
----
--0
----
----
----
----
--0
----
----
----
-Less:Other special charges
119.34%35.8K
94.08%-43.34K
105.80%42.78K
8.69%-11.25K
--110.27K
-1,159.34%-185.13K
---732.42K
---737.57K
---12.32K
----
-Write off
----
----
----
----
----
----
----
----
--0
--0
Other non- operating income (expenses)
-53.38%-2.27M
11,336.78%456.21K
---2.73K
--6.2K
--1.94M
---1.48M
-99.92%3.99K
----
----
----
Income before tax
-57.37%-13.75M
-80.73%-26.96M
32.13%-3.7M
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
Income tax
Net income
-57.37%-13.75M
-80.73%-26.96M
32.13%-3.7M
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
Net income continuous Operations
-57.37%-13.75M
-80.73%-26.96M
32.13%-3.7M
-18.24%-4.75M
-191.31%-9.77M
-317.89%-8.74M
18.18%-14.92M
-230.37%-5.46M
-254.96%-4.02M
38.94%-3.35M
Net income discontinuous operations
----
----
----
----
----
----
--0
----
----
----
Minority interest income
-18.45%-193.27K
-9.64%-781.55K
-604.65%-676.57K
403.70%571.43K
-113.34%-513.26K
13.24%-163.16K
-117.05%-712.81K
62.65%-96.02K
-163.67%-188.16K
-240.58K
Net income attributable to the parent company
-58.11%-13.56M
-84.30%-26.18M
43.54%-3.03M
-38.98%-5.32M
-197.34%-9.25M
-350.61%-8.58M
20.66%-14.2M
-284.38%-5.36M
-261.11%-3.83M
43.32%-3.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.11%-13.56M
-84.30%-26.18M
43.54%-3.03M
-38.98%-5.32M
-197.34%-9.25M
-350.61%-8.58M
20.66%-14.2M
-284.38%-5.36M
-261.11%-3.83M
43.32%-3.11M
Basic earnings per share
13.31%-3.06
37.50%-8.2
69.54%-0.71
71.40%-1.25
37.88%-3.23
-2.92%-3.53
56.16%-13.12
18.97%-2.331
-148.62%-4.37
42.86%-5.2
Diluted earnings per share
13.31%-3.06
37.50%-8.2
69.54%-0.71
71.40%-1.25
37.88%-3.23
-2.92%-3.53
56.16%-13.12
18.97%-2.331
-148.62%-4.37
42.86%-5.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -14.06%2.91M-3.57%15.32M-61.23%2.36M14.36%4.66M41.57%4.91M50.26%3.39M-18.84%15.88M202.91%6.09M45.48%4.07M-36.45%3.47M
Selling and administrative expenses 34.11%2.16M28.98%12.01M27.53%2.16M25.26%4.02M73.36%4.22M-18.51%1.61M-29.49%9.31M-11.66%1.69M19.42%3.21M-11.22%2.44M
-General and administrative expense 34.11%2.16M28.98%12.01M27.53%2.16M25.26%4.02M73.36%4.22M-18.51%1.61M-29.49%9.31M-11.66%1.69M19.42%3.21M-11.22%2.44M
Research and development costs -62.02%626.09K-54.58%2.76M-98.36%70.4K-33.51%495.22K-38.84%549.2K928.55%1.65M57.63%6.08M14,386.34%4.28M2,358.00%744.8K-44.24%897.99K
Depreciation amortization depletion -1.74%127.44K11.25%545.78K14.69%129.37K20.30%145.34K3.34%141.38K7.95%129.69K-80.43%490.57K-7.70%112.8K-17.71%120.81K-87.64%136.81K
-Depreciation and amortization -1.74%127.44K11.25%545.78K14.69%129.37K20.30%145.34K3.34%141.38K7.95%129.69K-80.43%490.57K-7.70%112.8K-17.71%120.81K-87.64%136.81K
Operating profit 14.06%-2.91M3.57%-15.32M61.23%-2.36M-14.36%-4.66M-41.57%-4.91M-50.26%-3.39M18.84%-15.88M-202.91%-6.09M-45.48%-4.07M36.45%-3.47M
Net non-operating interest income expense 84.06%-45.18K-172.82%-382.56K-56.47%50.34K-103.03%-4.66K-250.77%-144.84K-277.00%-283.4K-33.17%525.31K-24.80%115.64K-12.01%153.5K-48.40%96.07K
Non-operating interest income -----58.79%236.08K-116.87%-22.29K-38.72%100.42K-13.11%90.73K-61.04%67.22K-27.15%572.89K-14.12%132.08K-5.86%163.87K-43.91%104.42K
Non-operating interest expense -87.11%45.18K1,200.29%618.64K-541.89%-72.62K913.16%105.08K2,718.87%235.57K2,724.36%350.62K15,812.04%47.58K136,858.33%16.44K--10.37K--8.36K
Other net income (expense) -112.96%-10.8M-2,639.96%-11.26M-370.65%-1.39M11.45%-84.75K-21,187.11%-4.71M-302,296.54%-5.07M-19.92%443.19K152.25%514.89K-106.41%-95.71K110.41%22.33K
Gain on sale of security -124.98%-8.49M-3,909.49%-11.76M-494.73%-1.35M5.39%-102.2K-29,364.89%-6.53M-19,797.03%-3.77M-272.22%-293.22K-151.48%-226.67K79.14%-108.03K-96.80%22.33K
Special income (charges) -119.34%-35.8K-94.08%43.34K-105.80%-42.78K-8.69%11.25K---110.27K1,159.34%185.13K116.08%732.42K412.28%737.57K--12.32K--0
-Less:Impairment of capital assets ------0------------------0------------
-Less:Other special charges 119.34%35.8K94.08%-43.34K105.80%42.78K8.69%-11.25K--110.27K-1,159.34%-185.13K---732.42K---737.57K---12.32K----
-Write off ----------------------------------0--0
Other non- operating income (expenses) -53.38%-2.27M11,336.78%456.21K---2.73K--6.2K--1.94M---1.48M-99.92%3.99K------------
Income before tax -57.37%-13.75M-80.73%-26.96M32.13%-3.7M-18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M
Income tax
Net income -57.37%-13.75M-80.73%-26.96M32.13%-3.7M-18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M
Net income continuous Operations -57.37%-13.75M-80.73%-26.96M32.13%-3.7M-18.24%-4.75M-191.31%-9.77M-317.89%-8.74M18.18%-14.92M-230.37%-5.46M-254.96%-4.02M38.94%-3.35M
Net income discontinuous operations --------------------------0------------
Minority interest income -18.45%-193.27K-9.64%-781.55K-604.65%-676.57K403.70%571.43K-113.34%-513.26K13.24%-163.16K-117.05%-712.81K62.65%-96.02K-163.67%-188.16K-240.58K
Net income attributable to the parent company -58.11%-13.56M-84.30%-26.18M43.54%-3.03M-38.98%-5.32M-197.34%-9.25M-350.61%-8.58M20.66%-14.2M-284.38%-5.36M-261.11%-3.83M43.32%-3.11M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.11%-13.56M-84.30%-26.18M43.54%-3.03M-38.98%-5.32M-197.34%-9.25M-350.61%-8.58M20.66%-14.2M-284.38%-5.36M-261.11%-3.83M43.32%-3.11M
Basic earnings per share 13.31%-3.0637.50%-8.269.54%-0.7171.40%-1.2537.88%-3.23-2.92%-3.5356.16%-13.1218.97%-2.331-148.62%-4.3742.86%-5.2
Diluted earnings per share 13.31%-3.0637.50%-8.269.54%-0.7171.40%-1.2537.88%-3.23-2.92%-3.5356.16%-13.1218.97%-2.331-148.62%-4.3742.86%-5.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.17%
Sample Name
Sample Code
 +15.02%
Sample Name
Sample Code
 +14.13%
4
United States Oil Fund LP
USO
+13.24%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+10.87%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.62%
Sample Name
Sample Code
 +10.03%
Sample Name
Sample Code
 +9.02%
4
Hesai
HSAI
+7.55%
5
NIO Inc
NIO
+7.33%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -